Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How I vaccinate blood and marrow transplant recipients
Paul A. Carpenter, Janet A. Englund
Blood (2016) Vol. 127, Iss. 23, pp. 2824-2832
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
Joshua A. Hill, Susan K. Seo
Blood (2020) Vol. 136, Iss. 8, pp. 925-935
Open Access | Times Cited: 220
Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy
Kitsada Wudhikarn, Miguel‐Angel Perales
Bone Marrow Transplantation (2022) Vol. 57, Iss. 10, pp. 1477-1488
Open Access | Times Cited: 78
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update
Seth J. Rotz, Neel S. Bhatt, Betty K. Hamilton, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 4, pp. 349-385
Open Access | Times Cited: 21
Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation – A systematic review of randomized trials, observational studies and case reports
Evelina Croce, Christoph Hatz, Emile F.F. Jonker, et al.
Vaccine (2017) Vol. 35, Iss. 9, pp. 1216-1226
Open Access | Times Cited: 157
Late effects of blood and marrow transplantation
Yoshihiro Inamoto, Stephanie J. Lee
Haematologica (2017) Vol. 102, Iss. 4, pp. 614-625
Open Access | Times Cited: 146
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
Ibai Los‐Arcos, Gloria Iacoboni, Manuela Aguilar‐Guisado, et al.
Infection (2020) Vol. 49, Iss. 2, pp. 215-231
Open Access | Times Cited: 108
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
Ankit Kansagra, Noelle V. Frey, Merav Bar, et al.
Bone Marrow Transplantation (2019) Vol. 54, Iss. 11, pp. 1868-1880
Open Access | Times Cited: 107
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy
Ankit Kansagra, Noelle V. Frey, Merav Bar, et al.
Biology of Blood and Marrow Transplantation (2018) Vol. 25, Iss. 3, pp. e76-e85
Open Access | Times Cited: 98
Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients
Noga Shem‐Tov, Ronit Yerushalmi, Ivetta Danylesko, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 884-891
Open Access | Times Cited: 65
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
Roni Tamari, Ioannis Politikos, David A. Knorr, et al.
Blood Cancer Discovery (2021) Vol. 2, Iss. 6, pp. 577-585
Open Access | Times Cited: 58
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians
Eleftheria Kampouri, Carla S. Walti, Jordan Gauthier, et al.
Expert Review of Hematology (2022) Vol. 15, Iss. 4, pp. 305-320
Closed Access | Times Cited: 52
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
Alice S. Huang, Caroline Cicin‐Sain, Chloé Pasin, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 4, pp. 214.e1-214.e11
Open Access | Times Cited: 51
Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy
Gemma Reynolds, Victoria Hall, Benjamin W. Teh
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Open Access | Times Cited: 24
Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis
Christopher E. Dandoy, Monica I. Ardura, Genovefa A. Papanicolaou, et al.
Bone Marrow Transplantation (2017) Vol. 52, Iss. 8, pp. 1091-1106
Open Access | Times Cited: 77
Update: Vaccines in primary immunodeficiency
Francisco A. Bonilla
Journal of Allergy and Clinical Immunology (2017) Vol. 141, Iss. 2, pp. 474-481
Open Access | Times Cited: 65
Antibodies to vaccine-preventable infections after CAR-T-cell therapy for B-cell malignancies
Carla S. Walti, Elizabeth M. Krantz, Joyce Maalouf, et al.
JCI Insight (2021)
Open Access | Times Cited: 45
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101983-101983
Open Access | Times Cited: 20
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update
Seth J. Rotz, Neel S. Bhatt, Betty K. Hamilton, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 6, pp. 717-741
Closed Access | Times Cited: 5
Avaliação da vacinação dos pacientes submetidos ao transplante de medula óssea em centro de referência
Maíra Carvalho Gallucci, Karin Regina Luhn, Juliane Cristine de Brito, et al.
Revista Eletrônica Acervo Saúde (2025) Vol. 25, pp. e17946-e17946
Closed Access
Gynecological complications and treatment strategies in patients after hematopoietic stem cell transplantation
Kinga Wdowiarz, Małgorzata Reinholz-Jaskólska, Małgorzata Radowicka, et al.
Ginekologia Polska (2025)
Open Access
How I monitor long-term and late effects after blood or marrow transplantation
Smita Bhatia, Saro H. Armenian, Wendy Landier
Blood (2017) Vol. 130, Iss. 11, pp. 1302-1314
Open Access | Times Cited: 60
Immune function in childhood cancer survivors: a Children's Oncology Group review
Gregory M.T. Guilcher, Linda Rivard, Jennifer T. Huang, et al.
The Lancet Child & Adolescent Health (2021) Vol. 5, Iss. 4, pp. 284-294
Open Access | Times Cited: 33
Vaccination Coverage in Hematopoietic Stem Cell Transplant Patients
Angeles Bouzas-Rodríguez, Germán Molina-Romera, Juan Manuel Vázquez Lago, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 257-257
Open Access
Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care
Minoo Battiwalla, André Tichelli, Navneet S. Majhail
Biology of Blood and Marrow Transplantation (2016) Vol. 23, Iss. 2, pp. 184-192
Open Access | Times Cited: 43
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report
Juan Gea‐Banacloche, Krishna V. Komanduri, Paul A. Carpenter, et al.
Biology of Blood and Marrow Transplantation (2016) Vol. 23, Iss. 6, pp. 870-881
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top